138 related articles for article (PubMed ID: 32362654)
1. Tumour budding and tumour-stroma ratio in hepatocellular carcinoma.
Kairaluoma V; Kemi N; Pohjanen VM; Saarnio J; Helminen O
Br J Cancer; 2020 Jul; 123(1):38-45. PubMed ID: 32362654
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
[TBL] [Abstract][Full Text] [Related]
3. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.
Lv Z; Cai X; Weng X; Xiao H; Du C; Cheng J; Zhou L; Xie H; Sun K; Wu J; Zheng S
Surgery; 2015 Jul; 158(1):142-50. PubMed ID: 25890776
[TBL] [Abstract][Full Text] [Related]
4. Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients.
Zengin M
Pathol Res Pract; 2019 Nov; 215(11):152635. PubMed ID: 31564570
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
[TBL] [Abstract][Full Text] [Related]
7. Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding.
Dourado MR; Miwa KYM; Hamada GB; Paranaíba LMR; Sawazaki-Calone Í; Domingueti CB; Ervolino de Oliveira C; Furlan ECB; Longo BC; Almangush A; Salo T; Coletta RD
Histopathology; 2020 May; 76(6):906-918. PubMed ID: 31984527
[TBL] [Abstract][Full Text] [Related]
8. Tumour-stroma ratio and prognosis in gastric adenocarcinoma.
Kemi N; Eskuri M; Herva A; Leppänen J; Huhta H; Helminen O; Saarnio J; Karttunen TJ; Kauppila JH
Br J Cancer; 2018 Aug; 119(4):435-439. PubMed ID: 30057407
[TBL] [Abstract][Full Text] [Related]
9. Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study.
Smit MA; van Pelt GW; Terpstra V; Putter H; Tollenaar RAEM; Mesker WE; van Krieken JHJM
Int J Colorectal Dis; 2021 Dec; 36(12):2729-2737. PubMed ID: 34533595
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of tumor budding and tumor-stroma ratio in pulmonary metastasis of colorectal carcinoma.
Karjula T; Kemi N; Niskakangas A; Mustonen O; Puro I; Pohjanen VM; Kuopio T; Elomaa H; Ahtiainen M; Mecklin JP; Seppälä TT; Wirta EV; Sihvo E; Väyrynen JP; Yannopoulos F; Helminen O
Eur J Surg Oncol; 2023 Jul; 49(7):1298-1306. PubMed ID: 36841693
[TBL] [Abstract][Full Text] [Related]
11. Histological assessment of stromal maturity as a prognostic factor in surgically treated gastric adenocarcinoma.
Kemi NA; Eskuri M; Pohjanen VM; Karttunen TJ; Kauppila JH
Histopathology; 2019 Dec; 75(6):882-889. PubMed ID: 31173384
[TBL] [Abstract][Full Text] [Related]
12. The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy?
Courrech Staal EF; Wouters MW; van Sandick JW; Takkenberg MM; Smit VT; Junggeburt JM; Spitzer-Naaykens JM; Karsten T; Hartgrink HH; Mesker WE; Tollenaar RA
Eur J Cancer; 2010 Mar; 46(4):720-8. PubMed ID: 20044247
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of tumour-stroma ratio in triple-negative breast cancer.
Moorman AM; Vink R; Heijmans HJ; van der Palen J; Kouwenhoven EA
Eur J Surg Oncol; 2012 Apr; 38(4):307-13. PubMed ID: 22264965
[TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation of tumor-stroma ratio in patients with early stage cervical adenocarcinoma treated by surgery.
Pongsuvareeyakul T; Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Intaraphet S; Siriaunkgul S
Asian Pac J Cancer Prev; 2015; 16(10):4363-8. PubMed ID: 26028100
[TBL] [Abstract][Full Text] [Related]
15. A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance.
Strous MTA; Faes TKE; Gubbels ALHM; van der Linden RLA; Mesker WE; Bosscha K; Bronkhorst CM; Janssen-Heijnen MLG; Vogelaar FJ; de Bruïne AP
Clin Transl Oncol; 2022 Jun; 24(6):1047-1058. PubMed ID: 35064453
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
[TBL] [Abstract][Full Text] [Related]
17. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer.
Liu L; Xu L; Wu D; Zhu Y; Li X; Xu C; Chen K; Lin Y; Lao J; Cai P; Li X; Luo Y; Li X; Huang J; Lin T; Zhong W
EBioMedicine; 2024 Jun; 104():105152. PubMed ID: 38728838
[TBL] [Abstract][Full Text] [Related]
18. Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma.
Kang J; Su M; Xu Q; Wang C; Yuan X; Han Z
Oral Dis; 2023 Mar; 29(2):628-638. PubMed ID: 34455659
[TBL] [Abstract][Full Text] [Related]
19. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
20. Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
Eriksen AC; Andersen JB; Lindebjerg J; dePont Christensen R; Hansen TF; Kjær-Frifeldt S; Sørensen FB
Diagn Pathol; 2018 Mar; 13(1):20. PubMed ID: 29558947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
